Literature DB >> 24642341

Serum CA125 and NSE: biomarkers of disease severity in patients with silicosis.

Shen-Cun Fang1, Hai-Tao Zhang1, Cai-Ying Wang1, Ying-Ming Zhang2.   

Abstract

BACKGROUND: We investigated the clinical significance of tumor markers in patients with silicosis.
METHODS: Eighty silicosis patients without malignancy and 50 healthy volunteers were compared for serum tumor marker concentrations. Pulmonary function and several routine laboratory tests were performed. Correlation between serum tumor marker concentrations and severity markers for silicosis was analyzed. Tumor marker concentrations were detected in both blood and BALF samples in silicosis patients. The pre- and post-lavage differences in the serum tumor marker concentrations were also investigated. Immunohistochemical staining for tumor markers was performed in a lung biopsy specimen from a silicosis patient.
RESULTS: Both serum NSE and CA125 concentrations were significantly higher in cases compared with controls. Significant positive correlations were found between values of NSE and CA125 and LDH concentration. Significant negative correlations were also observed between values of NSE and CA125 and spirometric parameters. Patients with silicosis had higher concentrations of NSE in BALF than that in serum. 11 of 14 patients experienced a decrease in NSE concentrations following whole lung lavage. Immunohistochemical studies showed positive NSE staining in lung biopsy specimen.
CONCLUSIONS: Serum NSE and CA125 concentrations would provide valuable clinical information to assess disease severity in silicosis.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CA125; NSE; Silicosis; Tumor marker; Whole lung lavage

Mesh:

Substances:

Year:  2014        PMID: 24642341     DOI: 10.1016/j.cca.2014.03.005

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  6 in total

1.  In vitro selection of DNA aptamers for the development of chemiluminescence aptasensor for neuron-specific enolase (NSE) detection.

Authors:  Yue Zheng; Yunwang Zhao; Ya Di; Lei He; Shiqi Liao; Dongdong Li; Xiaofei Liu
Journal:  RSC Adv       Date:  2019-05-17       Impact factor: 4.036

2.  Inflammatory indices obtained from routine blood tests show an inflammatory state associated with disease progression in engineered stone silicosis patients.

Authors:  Alejandro García-Núñez; Gema Jiménez-Gómez; Antonio Hidalgo-Molina; Juan Antonio Córdoba-Doña; Antonio León-Jiménez; Antonio Campos-Caro
Journal:  Sci Rep       Date:  2022-05-17       Impact factor: 4.996

3.  Case of accelerated silicosis in a sandblaster.

Authors:  Beáta Hutyrová; Petra Smolková; Marie Nakládalová; Tomáš Tichý; Vítězslav Kolek
Journal:  Ind Health       Date:  2014-12-18       Impact factor: 2.179

4.  The CD14 (-159 C/T) SNP is associated with sCD14 levels and allergic asthma, but not with CD14 expression on monocytes.

Authors:  J J Nieto-Fontarigo; F J Salgado; M E San-José; M J Cruz; A Casas-Fernández; M J Gómez-Conde; L Valdés-Cuadrado; M Á García-González; P Arias; M Nogueira; F J González-Barcala
Journal:  Sci Rep       Date:  2018-03-07       Impact factor: 4.379

5.  Serum neuron-specific enolase: A promising biomarker of silicosis.

Authors:  Hong-Bo Huang; Jun-Ling Huang; Xiao-Ting Xu; Kun-Bo Huang; Yi-Jian Lin; Jie-Bin Lin; Xi-Bin Zhuang
Journal:  World J Clin Cases       Date:  2021-02-16       Impact factor: 1.337

6.  Association of pulmonary sequestration with elevated serum cancer antigen 125 levels: a case report.

Authors:  Guojie Teng; Xiuhong Nie; Dandan Wang
Journal:  J Int Med Res       Date:  2020-02       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.